Selecta Stock Active With Rights to MMA-101 and AskBio Buyout
While the price surge in shares of Selecta Biosciences (NASDAQ:SELB) [...]
SanaCurrents BioTech Back Study Returns Discussed
As you may have read recently or noticed, shares of [...]
SanaCurrents Following Stock Highs After Coronavirus Developments
Last Friday, the FDA granted emergency use authorization (EUA) to [...]
Antibe Pain Relief Drug Catalyst Update
SanaCurrents is closing its position in Antibe this week, due [...]
2019 Winding Down. A Retrospective from SanaCurrents
As 2019 winds to a close, SanaCurrents can look back [...]
New Approaches to Alzheimer’s After a String of Failures
Did you ever wonder how a company like Biogen, valued [...]
Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts
One of the strongest performing biopharmaceutical stocks this year is [...]
SanaCurrents Increasing Monthly Sentiment Report Frequency
SanaCurrents is increasing the frequency of its sentiment reports to subscribers [...]